Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems

ClinicalTrials.gov ID: NCT00002315

Public ClinicalTrials.gov record NCT00002315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Multicenter Study Comparing Oral 882C87 With Oral Acyclovir for Treatment of Localized Herpes Zoster in Immunocompromised Patients

Study identification

NCT ID
NCT00002315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Glaxo Wellcome
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • Netivudine Drug
  • Acyclovir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Simon - Williamson Clinic Birmingham Alabama 35211
SORRA / NC Research Ctr Birmingham Alabama 35234
Univ of Arizona / Univ Med Ctr Tucson Arizona 85724
Cedars Sinai Med Ctr Los Angeles California 90048
AIDS Community Research Consortium Redwood City California 94063
Saint Francis Mem Hosp San Francisco California 94109
Sunnyvale Med Clinic Sunnyvale California 94086
Clinical Research Consultants Trumbull Connecticut 06611
Med Associates Clinic Dubuque Iowa 52001
Oschner Clinic New Orleans Louisiana 70121
Washington Univ St Louis Missouri 63110
New Mexico Med Group Albuquerque New Mexico 87110
Jordon Diagnostics and Research Inc High Point North Carolina 27262
Hanover Med Specialists Wilmington North Carolina 28401
Oregon Research Group Eugene Oregon 97401
Oregon Health Sciences Univ Portland Oregon 97201
Roger Williams Med Ctr Providence Rhode Island 02908
Silver Lake Med Inc Providence Rhode Island 02909
Vanderbilt Med Ctr Nashville Tennessee 37232
N Texas Ctr for AIDS & Clin Rsch Dallas Texas 75219
MacGregor Med Association Houston Texas 77054
Univ TX Med Branch Nassau Bay Texas 77058
Infections Ltd / Physicians Med Ctr Tacoma Washington 98405
Med Consultants LTD Milwaukee Wisconsin 53215
Rhinelander Med Ctr Rhinelander Wisconsin 54501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →